Neurodegenerative clinical trials present unique challenges that extend beyond scientific and operational complexity. Disease progression, caregiver responsibilities, travel burden, complex assessments, and patient availability can all influence recruitment, retention, and the overall clinical trial experience. As the field continues to advance, incorporating the perspectives of patients and caregivers into clinical development is increasingly important to designing studies that are both scientifically rigorous and feasible for the populations they aim to serve.
Our upcoming webinar presented by Xtalks will explore practical strategies for integrating patient and caregiver centered approaches throughout the clinical development process including:
- Protocol Development
- Opportunities to Incorporate Advocacy Feedback Early
- Align Study Endpoints and Assessments
The discussion will also examine key barriers to participation and approaches to improving recruitment and retention. Speakers will share operational strategies informed by experience across different phase neurodegenerative programs, including considerations for site selection and readiness, visit burden, complex assessments, and global coordination.
As neurodegenerative development increasingly spans international populations, the webinar will address the additional considerations involved in conducting patient-centered studies across borders. Differences in patient engagement expectations, ethical considerations, and regulatory requirements can affect how patient and caregiver perspectives are incorporated into clinical research. Ensuring that patient-centered strategies align with global regulatory standards is essential for successful execution.
Finally, the webinar will connect patient-centered protocol design with real-world study execution, highlighting lessons learned from programs varying in phases. By bringing together clinical, operational, and patient-focused perspectives, the discussion will demonstrate how thoughtful trial design and execution can improve the experience for patients and caregivers while supporting the scientific and operational objectives of a clinical trial.
Key Takeaways
Attendees will gain actionable insights into designing and executing neurodegenerative clinical trials that balance scientific rigor, operational feasibility, and the needs of patients and caregivers – moving beyond the protocol to create a more meaningful clinical trial experienced.
An Industry Leader in Neurodegenerative Clinical Development
Accelerate the execution of your neurodegenerative disease study by partnering with a global CRO that not only understands the unique challenges of neurodegenerative diseases but also possesses the necessary experience to help you overcome them. As a scientifically-driven CRO, Medpace brings together a dedicated team of neuroscience experts who combine scientific leadership with operational excellence to help accelerate your neurodegenerative disease compound to approval.
